- Marriott (Los Angeles, CA)
- …monitor and protect property assets. * Comply with all Corporate Loss Prevention safety and security management guidelines and procedures. * Conduct periodic ... Information** **Job Number** 25085748 **Job Category** Loss Prevention & Security **Location** Los Angeles Airport Marriott, 5855 West Century Boulevard,… more
- Vera Therapeutics (Brisbane, CA)
- Title: Senior Director , Core Technology and IT Operations Location: Brisbane, California About Us: Vera Therapeutics (Nasdaq: VERA), is a late clinical-stage ... disorders. Additionally, Vera is developing VT-109, a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development, and MAU868, a monoclonal… more
- Vera Therapeutics (Brisbane, CA)
- Title: Executive Director , Pricing, Contracting and Government Location: Remote About Us: Vera Therapeutics (Nasdaq: VERA), is a late clinical-stage biotechnology ... disorders. Additionally, Vera is developing VT-109, a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development, and MAU868, a monoclonal… more
- Vera Therapeutics (Brisbane, CA)
- Job Title: Senior Director , Medical Affairs Operations Location: Remote About Us: Vera Therapeutics (Nasdaq: VERA), is a late clinical-stage biotechnology company ... disorders. Additionally, Vera is developing VT-109, a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development, and MAU868, a monoclonal… more
- RTX Corporation (El Segundo, CA)
- …Status Requirements:** The ability to obtain and maintain a US government issued security clearance is required. US citizenship is required, as only US citizens are ... eligible for a security clearance ** Security Clearance:** DoD Clearance: Secret...and sites into Raytheon's operating model. As the Associate Director , International Supply Chain Strategy, this position leads a… more
- Vera Therapeutics (Brisbane, CA)
- …disorders. Additionally, Vera is developing VT-109, a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development, and MAU868, a monoclonal ... The Clinical Project Associate will report to the Associate Director , Clinical Operations. Working with a cross functional team...Alert To all candidates: your personal information and online safety are a top priority for us. At Vera… more
- Vera Therapeutics (Brisbane, CA)
- …disorders. Additionally, Vera is developing VT-109, a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development, and MAU868, a monoclonal ... The Senior Manager, Clinical Regulatory will report to the Director , Clinical Regulatory and will be responsible for working...Alert To all candidates: your personal information and online safety are a top priority for us. At Vera… more